The FDA’s alert does not prevent Hims Hers Health from continuing to sell the treatment, but it raises questions about the future of these products in the market. The agency has stressed that ...

Compounding pharmacies use active pharmaceutical ingredients – the part of the medication that produces therapeutic effects – ...

Zacks Equity Research shares Hims & Hers Health HIMS as the Bull of the Day and AST SpaceMobile ASTS as the Bear of the D ...

Hims & Hers Health (HIMS) has emerged as a disruptive force in telehealth, leveraging technology and personalization to address highly-personal health conditions while achieving scalable profitability ...

The drugmaker Lilly announced topline results of a clinical trial of a new pill in the same drug class as injectables like ...

Pharma advertisers have kicked off 2025 with a bang, with the top 10 spenders throwing almost 30% more money behind their TV ...

Weight loss platform Noom launched a full-page print ad in The Wall Street Journal this week, calling on policymakers to ...

Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla ...

LifeMD used to be at a disadvantage to HIMS with its much bigger membership ... There's not a lot of cost structure with that business outside of ad spend and payroll. So most of that is ...

Hims & Hers Health, Inc. (NYSE ... These stocks are handpicked by our research director, Dr. Inan Dogan. • Ad-Free Browsing: Enjoy a year of investment research free from distracting banner ...